A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of SR147778 on weight loss over a period of
24 weeks when prescribed with a hypocaloric diet in obese patients. The secondary objective
is to assess the safety and tolerability of SR147778 and to assess the effect of SR147778 on
several secondary parameters (such as waist, metabolic parameters) over a period of 24 weeks
when prescribed with a hypocaloric diet in obese patients.